Skip to main content
×
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 10
  • Cited by
    This chapter has been cited by the following publications. This list is generated based on data provided by CrossRef.

    van der Pol, Thimo M. Hendriks, Vincent Rigter, Henk Cohn, Moran D. Doreleijers, Theo A. H. van Domburgh, Lieke and Vermeiren, Robert R. J. M. 2018. Multidimensional family therapy in adolescents with a cannabis use disorder: long-term effects on delinquency in a randomized controlled trial. Child and Adolescent Psychiatry and Mental Health, Vol. 12, Issue. 1,

    van der Pol, Thimo M. Henderson, Craig E. Hendriks, Vincent Schaub, Michael P. and Rigter, Henk 2018. Multidimensional Family Therapy Reduces Self-Reported Criminality Among Adolescents With a Cannabis Use Disorder. International Journal of Offender Therapy and Comparative Criminology, Vol. 62, Issue. 6, p. 1573.

    Zhou, Xinyu Qin, Bin Del Giovane, Cinzia Pan, Junxi Gentile, Salvatore Liu, Yiyun Lan, Xinghui Yu, Jia and Xie, Peng 2015. Efficacy and tolerability of antidepressants in the treatment of adolescents and young adults with depression and substance use disorders: a systematic review and meta-analysis. Addiction, Vol. 110, Issue. 1, p. 38.

    Apantaku-Olajide, Tunde James, Philip D. and Smyth, Bobby P. 2014. Association of Educational Attainment and Adolescent Substance Use Disorder in a Clinical Sample. Journal of Child & Adolescent Substance Abuse, Vol. 23, Issue. 3, p. 169.

    Hogue, Aaron Bobek, Molly Tau, Gregory Z. and Levin, Frances R. 2014. Clinical Strategies for Integrating Medication Interventions Into Behavioral Treatment for Adolescent ADHD: The Medication Integration Protocol. Child & Family Behavior Therapy, Vol. 36, Issue. 4, p. 280.

    Winhusen, Theresa M. Lewis, Daniel F. Riggs, Paula D. Davies, Robert D. Adler, Lenard A. Sonne, Susan and Somoza, Eugene C. 2011. Subjective Effects, Misuse, and Adverse Effects of Osmotic-Release Methylphenidate Treatment in Adolescent Substance Abusers with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology, Vol. 21, Issue. 5, p. 455.

    2011. Multidimensionale Familientherapie. p. 209.

    Hogue, Aaron and Liddle, Howard A. 2009. Family-based treatment for adolescent substance abuse: controlled trials and new horizons in services research. Journal of Family Therapy, Vol. 31, Issue. 2, p. 126.

    Riggs, Paula Levin, Frances Green, Alan I. and Vocci, Frank 2008. Comorbid Psychiatric and Substance Abuse Disorders: Recent Treatment Research. Substance Abuse, Vol. 29, Issue. 3, p. 51.

    Galanter, Marc Glickman, Linda and Singer, David 2007. An Overview of Outpatient Treatment of Adolescent Substance Abuse. Substance Abuse, Vol. 28, Issue. 2, p. 51.

    ×
  • Print publication year: 2006
  • Online publication date: August 2009

13 - Developmentally informed diagnostic and treatment considerations in comorbid conditions

from Part III - Comprehensive assessment and integrative treatment planning with adolescent substance abusers
Summary

A burgeoning of research into child and adolescent substance use in the 1990s has significantly advanced our understanding of adolescent substance use disorders (SUDs) and of effective treatment approaches (Muck et al., 2001; Drug Strategies, 2003). Developmental research has demonstrated that adolescents who present for drug treatment have a broad range of behavioral problems, skills deficits, academic difficulties, and family and mental health problems, which have generally been shaped by a series of environmental adversities and biological vulnerabilities from early childhood (Dawes et al., 2000; Hops et al., 2000; Tarter, 2002; Tims et al., 2002). Developmental research has also supported the development of a number of manual-guided, behavioral, cognitive–behavioral, and family-based modalities that integrate treatment across multiple problem domains (Deas & Thomas, 2001; Muck et al., 2001; Riggs & Whitmore, 1999). A growing research and clinical consensus indicates that substance treatment is most effective when it attends to the multiple psychosocial problems and medical and mental health needs of adolescents in addition to their drug abuse. Such multimodal treatment, including the concurrent assessment and treatment of psychiatric comorbidity, is recommended by the leading research and clinical professional organizations in the field (AACAP, 1997; Drug Strategies, 2003; NIDA, 1999). Despite these recommendations, implementation of integrated treatment of comorbidity in substance treatment programs has lagged behind the integration of other treatment services owing to a number of barriers, including a lack of research evaluating the safety and efficacy of psychotropic medications in adolescents with SUD (Sohlkhah & Wilens, 1998).

Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Adolescent Substance Abuse
  • Online ISBN: 9780511543968
  • Book DOI: https://doi.org/10.1017/CBO9780511543968
Please enter your name
Please enter a valid email address
Who would you like to send this to *
×
REFERENCES
AACAP (American Academy of Child and Adolescent Psychiatry) (1997). Practice parameters for the assessment and treatment of children and adolescents with substance use disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 36 (Suppl. 10), 140S–156S.
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th edn. Washington, DC: American Psychiatric Press.
Barkley, R. A., Fischer, M., Edelbrock, C. S., & Smallish, L. (1990). The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 546–557.
Biederman, J., Faraone, S. V., Milberger, S., et al. (1996). Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder? Findings from a four-year follow-up of children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1193–1204.
Brent, D. A., Holder, D., Kolko, D., et al. (1997). A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Archives of General Psychiatry, 54, 877–885.
Breslau, N., Davis, G. C., Andreski, P., Peterson, E. L., & Schultz, L. R. (1997). Psychiatric sequelae of posttraumatic stress disorder in women. Archives of General Psychiatry, 54, 81–87.
Bukstein, O. G., Glancy, L. J., & Kaminer, Y. (1992). Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 1041–1045.
Chiles, J. A., Miller, M. L., & Cox, G. B. (1980). Depression in an adolescent delinquent population. Archives of General Psychiatry, 37, 1179–1184.
Coatsworth, J. D., Santisteban, D. A., McBride, C. K., & Szapocznik, J. (2001): Brief strategic family therapy versus community control: engagement, retention, and an exploration of the moderating role of adolescent symptom severity. Family Process, 40, 313–332.
Cornelius, J. R., Salloum, I. M., Ehler, J. G., et al. (1997). Fluoxetine in depressed alcoholics: a double-blind placebo-controlled trial. Archives of General Psychiatry, 54, 700–705.
Crowley, T. J. & Riggs, P. D. (1995). Adolescent substance use disorder with conduct disorder and comorbid conditions. In Rahdert, E. & Czechowicz, (eds.), NIDA Research Monograph, Vol. 156: Adolescent Drug Abuse: Clinical Assessment and Therapeutic Interventions (pp. 49–111). Rockville, MD: National Institute on Drug Abuse.
Crowley, T. J., Mikulich, S. K., MacDonald, M., Young, S. E., & Zerbe, G. O. (1998). Substance-dependent, conduct-disordered adolescent males: severity of diagnosis predicts 2-year outcome. Drug and Alcohol Dependence, 49, 225–237.
Davies, R. D., Chapman, M. C., Hall, S. K., Mikulich, S. K., & Riggs, P. D. (2002). Correlates of social phobia in depressed adolescents with conduct disorder and substance dependence. Drug and Alcohol Dependence, 66: S41.
Dawes, M. A., Antelman, S. M., Vanyukov, M. M., et al. (2000). Developmental sources of variation in liability to adolescent substance use disorders. Drug and Alcohol Dependence, 61, 3–14.
Deas, D. & Thomas, S. E. (2001). An overview of controlled studies of adolescent substance abuse treatment. American Journal on Addictions, 10, 178–189.
Dishion, T. J., Patterson, G. R., Stoolmiller, M. & Skinner, M. L. (1991). Family, school, and behavioral antecedents to early adolescent involvement with antisocial peers. Developmental Psychology, 27, 172–180.
Donohue, B. & Azrin, N. (2001). Family behavior therapy. In Wagner, E. F. & Waldron, H. B. (eds.), Innovations in Adolescent Substance Abuse Interventions (pp. 205–227). Oxford, UK: Elsevier Science.
Drug Strategies (2003). Treating Teens: A Guide to Adolescent Drug Programs. Washington, DC: Drug Strategies.
Emslie, G. J., Rush, A. J., Weinberg, W. A., et al. (1997). A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry, 54, 1031–1037.
Forehand, R., Wierson, M., Frame, C., Kempston, T., & Armistead, L. (1991). Juvenile delinquency entry and persistence: do attention problems contribute to conduct problems?Journal of Behavioral and Experimental Psychiatry, 22, 261–264.
Garland, E. J. (1998). Intranasal abuse of prescribed methylphenidate. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 573–574.
Geller, B., Cooper, T. B., Sun, K., et al. (1998). Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 171–178.
Gittelman, R. S., Mannuzza, R. S., Shenker, R., & Bonagura, N. (1985). Hyperactive boys almost grown up: I. Psychiatric status. Archives of General Psychiatry, 42, 937–947.
Grella, C. E., Hser, Y., Joshi, V., & Rounds-Bryant, J. (2001). Drug treatment outcomes for adolescents with comorbid mental and substance use disordersJournal of Nervous and Mental Diseases, 189, 384–392.
Grilo, C. M., Becker, D. F., Walker, M. L., et al. (1995). Psychiatric comorbidity in adolescent inpatients with substance use disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1085–1091.
Godley, S. H., Meyers, R. J., Smith, J. E., et al. (2001). Cannabis Youth Treatment Series, Vol. 4: The Adolescent Community Reinforcement Approach for Adolescent Cannabis Users. Rockville, MD: Center for Substance Abuse Treatment.
Henggeler, S., Borduin, C., Melton, G., et al. (1991). Effects of multisystemic therapy on drug use and abuse in serious juvenile offenders: a progress report from two outcome studies. Family Dynamics of Addiction Quarterly, 1, 40–51.
Henggeler, S. W., Pickrel, S. G., Brondino, M. J. (1996). Eliminating (almost) treatment drop-out of substance abusing or dependent delinquents through home-based multisystemic therapy. American Journal of Psychiatry, 153, 427–428.
Henggeler, S. W., Pickrel, S. G., Brondino, M. J.(1999). Multisystemic treatment of substance abusing and dependent delinquents: outcomes, treatment fidelity, and transportability. Mental Health Services Research, 1, 171–184.
Henggeler, S., Schoenwald, S. K., Rowland, M. D., & Cunningham, P. B. (2002). Serious Emotional Disturbance in Children and Adolescents: Multisystemic Therapy. New York: Guilford Press.
Hops, H., Andrews, J. A., Duncan, S. C., Duncan, T. E., & Tildesley, E. (2000). Adolescent drug use development: a social interactional and contextual perspective. In Sameroff, A. J., Lewis, M., & Miller, S. M. (eds.), Handbook of Developmental Psychopathology, 2nd edn (pp. 589–605). New York: Plenum Press.
Jaffe, S. L. (2002). Failed attempts at intranasal abuse of Concerta. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 5.
Kaminer, Y., Tarter, R. E., Bukstein, O. G., & Kabene, M. (1992). Comparison between treatment completers and noncompleters among dually diagnosed, substance-abusing adolescents. Journal of the Amercian Academy of Child and Adolescent Psychiatry, 38, 693–699.
Kandel, D. B., Johnson, J. G., Bird, H. G., et al. (1997). Psychiatric disorders associated with substance use among children and adolescents: findings from the methods for the epidemiology of child and adolescent mental disorders (MECA) study. Journal of Abnormal Child Psychology, 25, 121–132.
Kazdin, A. E., Siegel, T. C., & Bass, D. (1992). Cognitive problem-solving skills training and parent management training in the treatment of antisocial behavior in children. Journal of Consulting and Clinical Psychology, 60, 733–747.
Lewinsohn, P. M., Hops, H., Roberts, R. E., Seeley, J. R., & Andrews, J. A. (1993). Adolescent psychopathology, I. prevalence and incidence of depression and other DSM-III-R disorders in high school students. Journal of Abnormal Psychology, 102, 133–144. [Erratum in Journal of Abnormal Psychology, 102, 517.]
Lewinsohn, P. M., Rohde, P., Seeley, J. R., & Klein, D. N. (2002). Comorbidity between depression and substance abuse. In Proceedings of the 2002 Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, CA.
Liddle, H. A. & Hogue, A. (2001). Multidimensional family therapy for adolescent substance abuse. In Wagner, E. F. & Waldron, H. B. (eds.), Innovations in Adolescent Substance Abuse Interventions (pp. 229–261). Oxford: Elsevier Science.
Liddle, H. A., Dakof, G. A., Parker, K., et al. (2001). Multidimensional family therapy for adolescent drug abuse: results of a randomized clinical trial. American Journal of Drug and Alcohol Abuse, 27, 651–688.
Lohman, M., Riggs, P., Hall, S. K., Mikulich, S. K., & Klein, C. A. (2002). Perceived motivations for treatment in depressed, substance-dependent adolescents with conduct disorder. In Proceedings of the 64th Annual Meeting of the College on Problems of Drug Dependence, Quebec City, Canada.
Mannuzza, S., Klein, R. G., Bessler, A., Malloy, P., & LaPadula, M. (1993). Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Archives in General Psychiatry 50, 565–576.
McLellan, A. T., Arndt, I. O., Metzger, D. S., Woody, G. E., & O'Brien, C. P. (1993). The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association, 269, 1953–1959.
Monti, P. M., Barnett, N. P., O'Leary, T. A., & Colby, S. M. (2001). Motivational enhancement for alcohol-involved adolescents. In Monti, P. M. & Colby, S. M. (eds.), Adolescents, Alcohol, and Substance Abuse: Reaching Teens through Brief Interventions (pp. 145–182), New York: Guilford Press.
Muck, R., Zempolich, K. A., Titus, J. C., et al. (2001). An overview of the effectiveness of adolescent substance abuse treatment models. Youth and Society, 33, 143–168.
Mufson, L., Weissman, M. M., Moreau, D., & Garfinkel, R. (1999). Efficacy of interpersonal psychotherapy for depressed adolescents. Archives of General Psychiatry, 56, 573–579.
NIDA (National Institute on Drug Abuse) (1999). Principles of Drug Addiction Treatment: A Research-based Guide. [NIDA Publication No. 99–4180.] Rockville, MD: National Institute on Drug Abuse.
Riggs, P. D. (1998). Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 331–332.
Riggs, P. D. & Davies, R. D. (2002). A clinical approach to integrating treatment for adolescent depression and substance abuse. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 10.
Riggs, P. D. & Whitmore, E. A. (1999). Substance use disorders and disruptive behavior disorders. In Hendren, R. L. (ed.), Review of Psychiatry, Vol. 18: Disruptive Behavior Disorders in Children and Adolescents (pp. 33–174). Washington, DC: American Psychiatric Press.
Riggs, P. D, Baker, S., Mikulich, S. K., Young, S. E., & Crowley, T. J. (1995). Depression in substance-dependent delinquents. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 764–771.
Riggs, P. D., Mikulich, S. K., Coffman, L. M., & Crowley, T. J. (1997). Fluoxetine in drug-dependent delinquents with major depression: an open trial. Journal of Child and Adolescent Psychopharmacology, 7, 87–95.
Riggs, P. D., Leon, S. L., Mikulich, S. K., & Coffman, L. M. (1998). An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 1271–1278.
Riggs, P. D., Mikulich, S. K., & Hall, S. (2001). Effects of pemoline on ADHD, antisocial behaviors, and substance use in adolescents with conduct disorder and substance use disorder. In Proceedings of the 63rd Annual Meeting of the College of Problems of Drug Dependence, Scottsdale.
Rohde, P., Lewinsohn, P. M., & Seeley, J. R. (1996). Psychiatric comorbidity with problematic alcohol use in high school students. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 101–109.
Sampl, S. & Kadden, R. (2001). Motivational Enhancement Therapy and Cognitive Behavioral Therapy for Adolescent Cannabis Users: 5 sessions (DHHS Publication No. 01-3486). Rockville, MD: Center for Substance Abuse Treatment.
Sohlkhah, R. & Wilens, T. E. (1998). Pharmacotherapy of adolescent alcohol and other drug use disorders. Alcohol Health and Research World, 22, 122–125.
Spencer, T. & Biederman, J. (2002). Non-stimulant treatment for attention-deficit hyperactivity disorder. Journal of Attention Disorders, 6(suppl. 1), S101–S107.
Swendsen, J. D. & Merikangas, K. R. (2000). The comorbidity of depression and substance use disorders. Clinical Psychology Review, 20, 173–189.
Szapocznik, J., Perez-Vidal, A., Brickman, A. L., et al. (1988). Engaging adolescent drug abusers and their families in treatment: a strategic structural systems approach. Journal of Consulting and Clinical Psychology, 56, 552–557.
Tarter, R. E. (2002). Etiology of adolescent substance abuse: a developmental perspective. American Journal on Addictions, 11: 171–191.
Tims, F. M., Dennis, M. L., Hamilton, N., et al. (2002). Characteristics and problems of 600 adolescent cannabis abusers in outpatient treatment. Addiction, 97(Suppl. 1): 46–57.
Wagner, E. F., Brown, S. A., Monti, P. M., Myers, M. G., & Waldron, H. B. (1999). Innovations in adolescent substance abuse intervention. Alcoholism: Clinical and Experimental Research, 23: 236–249.
Waldron, H. B., Slesnick, N., Brody, J., Turner, C., & Peterson, T. (2001). Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. Journal of Consulting and Clinical Psychology, 69: 802–813.
Whitmore, E. A., Mikulich, S. K., Thompson, L. L., et al. (1997). Influences on adolescent substance dependence: conduct disorder, depression, attention deficit hyperactivity disorder, and gender. Drug and Alcohol Dependence, 87, 97–107.
Wilens, T. E., Biederman, J., & Spencer, T. J. (1997). Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants. Journal of the American Academy of Child and Adolescent Psychiatry, 23, 45–48.
Wilens, T. E., Biederman, J., Millstein, R. B., et al. (1999). Risk for substance use disorders in youths with child- and adolescent-onset bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 680–685.
Wilens, T. E., Spencer, T. J., Biederman, J., et al. (2001). A controlled clinical trial of bupropion for attentional deficit hyperactivity disorder in adults. American Journal of Psychiatry, 158, 282–288.
Wilens, T., Faraone, S., Biederman, J., & Gunawardene, S. (2003). Does the stimulant pharmacotherapy of ADHD beget later substance abuse? A meta-analysis of the literature. Pediatrics, 111, 179–185.
Wise, B. K., Cuffe, S. P., & Fischer, T. (2001). Dual diagnosis and successful participation of adolescents in substance abuse treatment. Journal of Substance Abuse Treatment, 21, 161–165.